IKT

$0.00

(

0.00%

)
Quote details

stock

Inhibikase Therapeutics Inc

NASDAQ | IKT

1.59

USD

$0.00

(

0.00%

)

At Close (As of Dec 17, 2025)

$119.23M

Market Cap

-

P/E Ratio

-0.04

EPS

$3.88

52 Week High

$1.33

52 Week Low

HEALTHCARE

Sector

IKT Chart

Recent Chart
Price Action

IKT Technicals

Tags:

IKT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$26K
Total Revenue $0
Cost Of Revenue $26K
Costof Goods And Services Sold $26K
Operating Income -$29M
Selling General And Administrative $11M
Research And Development $17M
Operating Expenses $29M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $1.1M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $26K
Income Before Tax -$28M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$28M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$27M
Net Income -$28M

Revenue & Profitability

Earnings Performance

IKT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $99M
Total Current Assets $98M
Cash And Cash Equivalents At Carrying Value $56M
Cash And Short Term Investments $56M
Inventory -
Current Net Receivables -
Total Non Current Assets $149K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $41M
Other Current Assets $908K
Other Non Current Assets -
Total Liabilities $3.7M
Total Current Liabilities $3.7M
Current Accounts Payable $943K
Deferred Revenue -
Current Debt -
Short Term Debt $111K
Total Non Current Liabilities $0
Capital Lease Obligations $111K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $111K
Other Current Liabilities $2.7M
Other Non Current Liabilities -
Total Shareholder Equity $95M
Treasury Stock -
Retained Earnings -$94M
Common Stock $69K
Common Stock Shares Outstanding $69M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$26K
Total Revenue $0
Cost Of Revenue $26K
Costof Goods And Services Sold $26K
Operating Income -$29M
Selling General And Administrative $11M
Research And Development $17M
Operating Expenses $29M
Investment Income Net -
Net Interest Income $1.1M
Interest Income $1.1M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $26K
Income Before Tax -$28M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$28M
Comprehensive Income Net Of Tax -
Ebit -$28M
Ebitda -$27M
Net Income -$28M

IKT News

IKT Profile

Inhibikase Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Inhibikase Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Atlanta, dedicated to advancing innovative treatments for Parkinson's disease and related neurodegenerative disorders. The company employs a distinctive dual-targeting approach to tackle both central and peripheral neurodegeneration, thereby addressing significant unmet needs in patient care. With a robust pipeline of clinical candidates, Inhibikase is well-positioned to substantially impact the treatment landscape and improve the quality of life for individuals living with these challenging conditions.

LPTX
+368.57%
$2.05
ATPC
+56.44%
$0.14
VYNE
+48.99%
$0.60
NVDA
-3.81%
$170.94
YCBD
+58.74%
$2.27
PAVS
-13.47%
$0.01
DRCT
+10.45%
$0.07
YGMZ
-61.42%
$0.02
IRBT
+0.23%
$0.76
TSLA
-4.61%
$467.26
CGC
+4.91%
$1.92
PLUG
-5.67%
$2.16
WOK
+4.25%
$0.05
AVGO
-4.47%
$326.02
VTGN
-80.25%
$0.86
GRAB
-1.61%
$4.87
WBD
-2.38%
$28.21
ASST
-4.60%
$0.82
AXDX
-61.36%
$0.03
RXRX
+11.42%
$4.68
SNAP
+1.76%
$7.50
RZLV
-19.19%
$2.40
PFE
-1.91%
$25.04
ONDS
-8.89%
$7.37
F
-2.63%
$13.31
VIVK
-14.57%
$0.05
AAL
-3.00%
$15.51
PLTD
+5.77%
$6.68
BMNR
-6.59%
$29.32
INTC
-3.37%
$36.05
BMNU
-13.05%
$5.73
BITF
-4.52%
$2.32
ADAP
-15.14%
$0.05
NFLX
+0.23%
$94.79
PLTR
-5.57%
$177.29
ORCL
-5.40%
$178.46
AAPL
-1.00%
$271.84
SOFI
-4.92%
$25.27
LAZR
-27.79%
$0.22
SRXH
-0.50%
$0.37
CRWV
-7.12%
$64.55
CIFR
-4.00%
$14.39
MARA
-7.10%
$9.93
ACHR
-4.65%
$7.58
WULF
-10.93%
$11.57
AMZN
-0.57%
$221.27
GOOGL
-3.21%
$296.72
SOND
-23.45%
$0.12
BYND
-4.54%
$1.05
MU
-3.00%
$225.52
DNN
-4.61%
$2.48
ADTX
+22.53%
$1.74
RMBL
+60.50%
$3.21
T
+1.20%
$24.36
LNW
-3.71%
$86.22
PCSA
+122.29%
$6.68
ADD
-25.47%
$0.05
IVP
-5.80%
$0.04
KVUE
+0.17%
$17.28
BBD
-1.19%
$3.31
HOOD
-3.01%
$115.80
RIG
+2.86%
$3.95
BAC
-0.47%
$54.55
SRM
+53.27%
$10.30
RGTI
-6.21%
$22.47
IREN
-7.67%
$33.78
RIVN
-1.50%
$17.63
AMD
-5.28%
$198.11
UDMY
+12.66%
$6.05
HPE
-1.15%
$24.02
VHAI
0.00%
$0.00
NAKA
-4.14%
$0.36
TLRY
-7.60%
$12.88
ITUB
-2.08%
$7.04
OCG
-4.24%
$0.14
APLD
-9.24%
$22.00
BTBT
-6.19%
$1.97
GOOG
-3.14%
$298.06
NIO
-3.37%
$4.86
QBTS
-6.73%
$23.80
BTG
+0.43%
$4.57
VICI
+1.87%
$28.39
UBER
-2.19%
$79.14
CPNG
-2.02%
$22.72
CMG
+3.75%
$37.00
CLSK
-3.20%
$11.48
AG
-0.12%
$16.38
VALE
+0.55%
$12.79
SMCI
-5.74%
$29.84
PBR
-0.16%
$11.77
AKAN
-0.67%
$0.74
AMC
-5.69%
$1.82
HBAN
+0.68%
$17.75
RKLB
-2.75%
$53.96
AFMD
-34.94%
$0.18
QS
-0.92%
$10.74
MSFT
-0.05%
$476.12
PCG
+2.68%
$15.68
TWO
+12.10%
$11.11
ABEV
-1.17%
$2.52
LPTX
+368.57%
$2.05
ATPC
+56.44%
$0.14
VYNE
+48.99%
$0.60
NVDA
-3.81%
$170.94
YCBD
+58.74%
$2.27
PAVS
-13.47%
$0.01
DRCT
+10.45%
$0.07
YGMZ
-61.42%
$0.02
IRBT
+0.23%
$0.76
TSLA
-4.61%
$467.26
CGC
+4.91%
$1.92
PLUG
-5.67%
$2.16
WOK
+4.25%
$0.05
AVGO
-4.47%
$326.02
VTGN
-80.25%
$0.86
GRAB
-1.61%
$4.87
WBD
-2.38%
$28.21
ASST
-4.60%
$0.82
AXDX
-61.36%
$0.03
RXRX
+11.42%
$4.68
SNAP
+1.76%
$7.50
RZLV
-19.19%
$2.40
PFE
-1.91%
$25.04
ONDS
-8.89%
$7.37
F
-2.63%
$13.31
VIVK
-14.57%
$0.05
AAL
-3.00%
$15.51
PLTD
+5.77%
$6.68
BMNR
-6.59%
$29.32
INTC
-3.37%
$36.05
BMNU
-13.05%
$5.73
BITF
-4.52%
$2.32
ADAP
-15.14%
$0.05
NFLX
+0.23%
$94.79
PLTR
-5.57%
$177.29
ORCL
-5.40%
$178.46
AAPL
-1.00%
$271.84
SOFI
-4.92%
$25.27
LAZR
-27.79%
$0.22
SRXH
-0.50%
$0.37
CRWV
-7.12%
$64.55
CIFR
-4.00%
$14.39
MARA
-7.10%
$9.93
ACHR
-4.65%
$7.58
WULF
-10.93%
$11.57
AMZN
-0.57%
$221.27
GOOGL
-3.21%
$296.72
SOND
-23.45%
$0.12
BYND
-4.54%
$1.05
MU
-3.00%
$225.52
DNN
-4.61%
$2.48
ADTX
+22.53%
$1.74
RMBL
+60.50%
$3.21
T
+1.20%
$24.36
LNW
-3.71%
$86.22
PCSA
+122.29%
$6.68
ADD
-25.47%
$0.05
IVP
-5.80%
$0.04
KVUE
+0.17%
$17.28
BBD
-1.19%
$3.31
HOOD
-3.01%
$115.80
RIG
+2.86%
$3.95
BAC
-0.47%
$54.55
SRM
+53.27%
$10.30
RGTI
-6.21%
$22.47
IREN
-7.67%
$33.78
RIVN
-1.50%
$17.63
AMD
-5.28%
$198.11
UDMY
+12.66%
$6.05
HPE
-1.15%
$24.02
VHAI
0.00%
$0.00
NAKA
-4.14%
$0.36
TLRY
-7.60%
$12.88
ITUB
-2.08%
$7.04
OCG
-4.24%
$0.14
APLD
-9.24%
$22.00
BTBT
-6.19%
$1.97
GOOG
-3.14%
$298.06
NIO
-3.37%
$4.86
QBTS
-6.73%
$23.80
BTG
+0.43%
$4.57
VICI
+1.87%
$28.39
UBER
-2.19%
$79.14
CPNG
-2.02%
$22.72
CMG
+3.75%
$37.00
CLSK
-3.20%
$11.48
AG
-0.12%
$16.38
VALE
+0.55%
$12.79
SMCI
-5.74%
$29.84
PBR
-0.16%
$11.77
AKAN
-0.67%
$0.74
AMC
-5.69%
$1.82
HBAN
+0.68%
$17.75
RKLB
-2.75%
$53.96
AFMD
-34.94%
$0.18
QS
-0.92%
$10.74
MSFT
-0.05%
$476.12
PCG
+2.68%
$15.68
TWO
+12.10%
$11.11
ABEV
-1.17%
$2.52

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.